Ascendis Pharma Issues 177,267 Shares from Warrant Exercise at $121.57

Ascendis Pharma A/S announced the closing of an exercise window for its outstanding warrants on June 29, 2026. This resulted in the issuance of 177,267 new ordinary shares, increasing the company's aggregate share capital by nominal DKK 177,267. The total share capital now stands at nominal DKK 66,189,926. The average cash consideration received for these shares was approximately $121.57 per share, and the company's articles of association were amended.